BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 1716432)

  • 1. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Meyer AL; Benson JM; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1996 Nov; 157(9):4230-8. PubMed ID: 8892661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
    al-Sabbagh A; Miller A; Santos LM; Weiner HL
    Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
    J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
    Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
    J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
    Higgins PJ; Weiner HL
    J Immunol; 1988 Jan; 140(2):440-5. PubMed ID: 2447178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
    Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
    Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
    Malotky MK; Pope L; Miller SD
    J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic-relapsing experimental autoimmune encephalomyelitis. Myelin basic protein induces suppression of blastogenesis during remissions but not during exacerbations.
    Lyman WD; Brosnan CF; Raine CS
    J Neuroimmunol; 1985; 7(5-6):345-53. PubMed ID: 2579093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
    J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
    Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
    Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.
    Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H
    J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane.
    Lebar R; Lubetzki C; Vincent C; Lombrail P; Boutry JM
    Clin Exp Immunol; 1986 Nov; 66(2):423-34. PubMed ID: 2434274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.
    Tan LJ; Kennedy MK; Dal Canto MC; Miller SD
    J Immunol; 1991 Sep; 147(6):1797-802. PubMed ID: 1716280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
    Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
    J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.